News & Perspective

Jun 13, 2007

Jun 13, 2007

Glaxo to give 50 million doses of H5N1 vaccine to WHO

(CIDRAP News) – GlaxoSmithKline (GSK) promised today to give 50 million doses of its H5N1 "prepandemic" influenza vaccine to the World Health Organization (WHO) for distribution to poor countries.

The vaccine will be delivered over 3 years and be enough to vaccinate 25 million people at two doses each, the United Kingdom–based drug company said in a news release.